http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0824100-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
| filingDate | 1997-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2000-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdac91fc5a325f887f8fd2acb3d9e900 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f62a1ded1654792407f8cb47c706ed6 |
| publicationDate | 2000-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0824100-B1 |
| titleOfInvention | Piperidinylamino tricyclic compouds as substance P antagonists |
| abstract | This invention provides a compound of the formula: <CHEM> and its pharmaceutically acceptable salts, wherein Ar<1> is selected from groups of the following formulae: <CHEM> wherein, R<1> and R<2> are independently hydrogen or C1-C6 alkyl; W is (CH2)n wherein n is from 1 to 3, or -CH=CH-; X is C1-C6 alkoxy or halo C1-C6 alkoxy; and Ar<2> is phenyl optionally substituted by halogen atom. These compounds are useful in the treatment of a gastrointestinal disorder, a central nervous system (CNS) disorder, an inflammatory disease, emesis, urinary incontinence, pain, migraine, sunburn, angiogenesis, diseases, disorders and adverse conditions caused by Helicobacter pylori, or the like in a mammalian subject, especially humans. |
| priorityDate | 1996-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 185.